Evidence map›Paper›PMID 34254834›Full record

Trial reportJournal of endourology2021

Prospective Randomized Evaluation of Idiopathic Hyperoxaluria Treatments.

Mantu Gupta, Blair Gallante, Jacob N Bamberger, Johnathan A Khusid, Egor Parkhomenko, Ryan Chandhoke, Jillian Capodice, William Atallah

Abstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Journal of endourology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Guideline
  2. Potential of Orally Administered Quercetin, Hesperidin, andInternational journal of molecular sciences · 2025
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Diet and Stone Disease in 2022.Journal of clinical medicine · 2022
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Mantu GuptaDepartment of Urology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Blair GallanteDepartment of Urology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.ORCID 0000-0002-0650-3309
Jacob N BambergerDepartment of Urology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.ORCID 0000-0002-6763-0811
Johnathan A KhusidDepartment of Urology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.ORCID 0000-0002-7966-252X
Egor ParkhomenkoDepartment of Urology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Ryan ChandhokeDepartment of Urology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Jillian CapodiceDepartment of Urology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
William AtallahDepartment of Urology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Icahn School of Medicine at Mount Sinai · USBoston University · USKaiser Permanente San Diego Medical Center · USSUNY Downstate Health Sciences University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

HyperoxaluriaKidney CalculiDietHumansOxalatesProspective StudiesRecurrenceOxalatesdiet therapyhyperoxaluriamagnesiumnephrolithiasisvitamin B6

Identifiers

PMID34254834
OpenAlexW3177592631

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.